Clinical trial sponsors and monitors should take a holistic perspective of patients as individuals and trial participants.
Sites and patients should consider themselves as an integral element crucial for the success of the trial and advances in medicine.
Patient advocates and organizations should have an independent voice with regulators, including revised endpoints.

свернуть